UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Primary CNS Lymphoma

Journal of clinical oncology, 2017-07, Vol.35 (21), p.2410-2418

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2404-2415

2016

Link zum Volltext

Verfügbarkeit prüfen

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

Blood, 2015-02, Vol.125 (9), p.1403-1410

2015

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

Neuro-oncology (Charlottesville, Va.), 2019-02, Vol.21 (3), p.296-305

2019

Link zum Volltext

Verfügbarkeit prüfen

Introduction of novel agents in the treatment of primary CNS lymphoma

Neuro-oncology (Charlottesville, Va.), 2019-02, Vol.21 (3), p.306-313

2019

Link zum Volltext

Verfügbarkeit prüfen

An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells

Science (American Association for the Advancement of Science), 2013-05, Vol.340 (6132), p.626-630

2013

Link zum Volltext

Verfügbarkeit prüfen

Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?

Journal of clinical oncology, 2023-03, Vol.41 (9), p.1649-1651

Grommes, Christian

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

Blood, 2019-01, Vol.133 (5), p.436-445

2019

Link zum Volltext

Verfügbarkeit prüfen

Update on Novel Therapeutics for Primary CNS Lymphoma

Cancers, 2021-10, Vol.13 (21), p.5372

2021

Link zum Volltext

Verfügbarkeit prüfen

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

Neuro-oncology (Charlottesville, Va.), 2021-07, Vol.23 (7), p.1056-1071

2021

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial

Clinical cancer research, 2016-10, Vol.22 (19), p.4786-4796

2016

Link zum Volltext

Verfügbarkeit prüfen

Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas

Journal for immunotherapy of cancer, 2017-12, Vol.5 (1), p.99-7, Article 99

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma

Clinical cancer research, 2014-10, Vol.20 (19), p.5023-5031

2014

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib in PCNSL: The Curious Cases of Clinical Responses and Aspergillosis

Cancer cell, 2017-06, Vol.31 (6), p.731-733

2017

Link zum Volltext

Verfügbarkeit prüfen

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study

BMC cancer, 2022-01, Vol.22 (1), p.60-60, Article 60

2022

Link zum Volltext

Verfügbarkeit prüfen

EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer

Nature communications, 2017-12, Vol.8 (1), p.2035-12, Article 2035

2017

Link zum Volltext

Verfügbarkeit prüfen

NCOG-36. LONG-TERM SURVIVAL AND COGNITIVE FUNCTION FOLLOW UP OF PRIMARY CNS LYMPHOMA TREATED WITH R-MVP FOLLOWED BY HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANT CONSOLIDATION

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi159-vi160

2021

Link zum Volltext

Verfügbarkeit prüfen

Primary central nervous system lymphoma

Blood, 2022-09, Vol.140 (9), p.971-979

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Single Agent Ibrutinib in Recurrent/Refractory Primary and Secondary CNS Lymphoma

Blood, 2015-12, Vol.126 (23), p.3960-3960

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-302: Potential role of larotrectinib (LOXO-101), a selective pan-TRK inhibitor, in NTRK fusion-positive recurrent glioblastoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.LB-302-LB-302

2017

Link zum Volltext

Verfügbarkeit prüfen

Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma

Journal of neuro-oncology, 2011-04, Vol.102 (2), p.335-339

2011

Link zum Volltext

Verfügbarkeit prüfen

Regulation of Microglial Phagocytosis and Inflammatory Gene Expression by Gas6 Acting on the Axl/Mer Family of Tyrosine Kinases

Journal of neuroimmune pharmacology, 2008-06, Vol.3 (2), p.130-140

2008

Link zum Volltext

Verfügbarkeit prüfen

SL3 PRIMARY CNS LYMPHOMA: CURRENT CONCEPTS AND THERAPEUTIC PERSPECTIVES

Neuro-oncology advances, 2019-12, Vol.1 (Supplement_2), p.ii4-ii4

Grommes, Christian

2019

Link zum Volltext

Verfügbarkeit prüfen

Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats

Stroke (1970), 2002-12, Vol.33 (12), p.3006-3011

2002

Link zum Volltext

Verfügbarkeit prüfen

Primary Central Nervous System Lymphomas

Hematology/oncology clinics of North America, 2022-02, Vol.36 (1), p.147

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 157

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(153)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Englisch
(154)
Japanisch
(25)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Primary CNS Lymphoma

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma

Introduction of novel agents in the treatment of primary CNS lymphoma

An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells

Circulating Tumor DNA in the Blood: A New Frontier in Primary CNS Lymphoma?

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

Update on Novel Therapeutics for Primary CNS Lymphoma

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)

Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial

Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas

Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma

Ibrutinib in PCNSL: The Curious Cases of Clinical Responses and Aspergillosis

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study

EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer

NCOG-36. LONG-TERM SURVIVAL AND COGNITIVE FUNCTION FOLLOW UP OF PRIMARY CNS LYMPHOMA TREATED WITH R-MVP FOLLOWED BY HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANT CONSOLIDATION

Primary central nervous system lymphoma

Phase I Study of Single Agent Ibrutinib in Recurrent/Refractory Primary and Secondary CNS Lymphoma

Abstract LB-302: Potential role of larotrectinib (LOXO-101), a selective pan-TRK inhibitor, in NTRK fusion-positive recurrent glioblastoma

Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma

Regulation of Microglial Phagocytosis and Inflammatory Gene Expression by Gas6 Acting on the Axl/Mer Family of Tyrosine Kinases

SL3 PRIMARY CNS LYMPHOMA: CURRENT CONCEPTS AND THERAPEUTIC PERSPECTIVES

Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats

Primary Central Nervous System Lymphomas

Suchergebnisse filtern